)
Ashiqul Haque
Technical Lead Vaccine Development,
Univercells
Dr. Ashiqul Haque is a seasoned technical lead in vaccine development, currently at Univercells in Belgium, with extensive expertise in RNA vaccine technologies. With over five years of experience across research and development, his work spans from early-stage RNA therapeutic development to leading programs on lipid nanoparticles for mRNA delivery. He previously held roles at Ziphius Vaccines, contributing significantly to analytical and process development. Dr. Haque earned his PhD from the University of Tübingen, where he specialized in gene therapy and Cas9 mRNA activity. His work is known for bridging research with clinical application in immunogenicity and drug delivery.